1. Home
  2. PGEN vs VERX Comparison

PGEN vs VERX Comparison

Compare PGEN & VERX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$4.21

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Logo Vertex Inc.

VERX

Vertex Inc.

N/A

Current Price

$17.25

Market Cap

2.8B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
PGEN
VERX
Founded
1998
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
PGEN
VERX
Price
$4.21
$17.25
Analyst Decision
Buy
Buy
Analyst Count
4
15
Target Price
$13.67
★ $20.85
AVG Volume (30 Days)
★ 6.8M
1.4M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.12
N/A
Revenue
$230,981,000.00
★ $748,444,000.00
Revenue This Year
$2,380.31
$10.85
Revenue Next Year
$84.01
$10.46
P/E Ratio
★ $34.63
$302.25
Revenue Growth
N/A
★ 12.25
52 Week Low
$3.04
$10.21
52 Week High
$8.98
$20.82

Technical Indicators

Market Signals
Indicator
PGEN
VERX
Relative Strength Index (RSI) 31.74 61.96
Support Level $3.89 $10.89
Resistance Level $4.41 $18.53
Average True Range (ATR) 0.36 0.73
MACD -0.01 -0.10
Stochastic Oscillator 16.78 63.84

Price Performance

Historical Comparison
PGEN
VERX

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About VERX Vertex Inc.

Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.

Share on Social Networks: